MYE · Myers Industries, Inc. · Stock research

Current Thesis

The 2026-07-30 Q2 report settled the question the earlier notes framed — whether the June–July re-rate was a top — and it settled upward: adjusted EPS from continuing operations of $0.53 against $0.32 consensus (+60.6% YoY) on net sales of $179.2M (+9.8% YoY, versus a $167.66M forecast). Shares marked a 52-week high of $36.74 in the days after and have gone sideways-to-lower since, with a reference close of $33.53 on 2026-08-21, 8.7% under that high. Against the $33.00 close of 2026-08-14 the price is barely changed; the momentum reading is not — RSI(14) fell from 51.4 to 29.6 over the same stretch, which implies the tape traded materially lower intra-week before recovering into the close (an inference drawn from the two oscillator readings, not from an observed intraday low). The narrative leg an investor is buying is unchanged: CEO Aaron Schapper's "Focused Transformation" pulls Myers out of distribution — Myers Tire Supply has been in held-for-sale and discontinued-operations accounting since 2026-03-31 — and concentrates capital behind Signature Systems composite matting and the food-and-beverage container platform, leaving a manufacturing-only portfolio at structurally higher margin. What the past month has not produced is a fresh bid: no company headline since the print, no second deep sponsor, and no dated event before the quarterly dividend declaration.

Bullish and bearish views on Myers Industries, Inc.

The model's bull view on Myers Industries, Inc. (MYE), in brief: Q2 2026 (reported 2026-07-30): adjusted EPS from continuing operations $0.53 vs $0.32 consensus, +60.6% YoY; GAAP continuing-operations EPS $0.50, +92.3% YoY. The bear view: The resin pass-through only half-worked. Both cases follow in full.

Bull Case

• Q2 2026 (reported 2026-07-30): adjusted EPS from continuing operations $0.53 vs $0.32 consensus, +60.6% YoY; GAAP continuing-operations EPS $0.50, +92.3% YoY. Second consecutive large beat after Q1's $0.44 vs $0.28 on 2026-05-07.
• The margin structure moved, not only the mix: Q2 gross margin 34.3%, up 300 bps from 31.3% a year earlier; adjusted EBITDA margin 21.8%, up 350 bps; operating income $31.2M, +57.1%, for a 17.4% operating margin.
• Growth sits where the transformation says it should. Q2 Infrastructure end-market sales $48.6M, +52% YoY; Food & Beverage $21.3M, +48% YoY — Signature Systems matting and the container platform carried the quarter.
• Deleveraging is dated and measured: net leverage 1.9x at Q2 versus 2.2x at Q1, net debt down $21.2M in the quarter, free cash flow $26.5M (+10.5% YoY), cash $47.6M, total liquidity $292.3M.
• The 2026-07-28 8-K amended the credit agreement into a $250M revolving facility and a $250M term loan, both maturing 2031, replacing facilities that matured in 2027 and 2029. Refinancing risk pushed out five years, funded with debt, with no equity sold into the July advance.
• KeyBanc's Christian Zyla carries an Overweight with a $37 target set 2026-06-30 (raised from $26), framed on 15.3x FY2028 EPS and an 8% free-cash-flow yield.

Bear Case

• The resin pass-through only half-worked. Q2 gross margin of 34.3% is 40 bps below the 34.7% adjusted gross margin reported for Q1, even while expanding 300 bps YoY. Management's 2026-06-01 framing was Q2 pressure from HD-polyethylene input costs with recovery in H2 through pricing; H2 remains the unproven leg and the first reading on it is roughly ten weeks out.
• Growth is narrow. Of five reported end markets in Q2, Vehicle fell 19% YoY to $20.5M and Consumer fell 14% to $22.5M; Industrial, the largest at $66.3M, grew 2%. Two of five lines are doing the work.
• The divestiture is still unsigned. MTS has been held-for-sale since 2026-03-31, already carries a $19.5M impairment taken in Q1 that drove a $15.6M discontinued-operations loss and a $1.8M net loss, and the close is guided only to "2026" with no announced buyer and no price.
• No quantitative FY2026 guidance accompanied the Q2 report — only qualitative end-market direction. There is no company-issued number against which H2 can be graded.
• Price has outrun the published sell-side. The $33.53 close of 2026-08-21 sits above the $31.50 average twelve-month target shown by WallStreetZen on 2026-08-23 (high $37, low $26). With coverage one desk deep, a single rating change has already moved the stock 14% in a session (2026-06-30).

Setup & Price Structure

• Reference close $33.53 on 2026-08-21; 52-week high $36.74; a three-month price change of +51.2%. The post-print range has been bounded by the $36.74 high above and roughly $33 below. The pre-print consolidation shelf sits near $31, the June breakout base near $27.
• RSI(14) at 29.6 on 2026-08-21 against 51.4 on 2026-08-14, on an essentially flat close. That is either a momentum reset inside an intact uptrend or the opening of distribution; the two readings alone do not separate the cases, and the next 30 days contain nothing that would.
• The narrative is maturing. The two attention-generating events are dated and behind — the 2026-06-30 KeyBanc target move to $37 from $26 that produced a 14% session, and the 2026-07-30 beat. In the weeks since the print the news feed has produced no new company headline, the sponsor base has not widened, and price is holding well above where it traded pre-print. The narrative still works; the flow behind it has thinned.
• Crowding and positioning observables, stated as observables: the stock trades above the aggregate twelve-month target displayed by aggregators as of 2026-08-23; retail-facing coverage clustered around the 2026-06-30 gainers list and the Q2 beat, with nothing since; the July capital raise was debt, not equity, so there is no issuance into strength; the next earnings date is roughly ten weeks out, so no print compresses the tape inside the current window.

Catalyst Calendar (next 30 days)

• ~2026-09-02 (est.) — Quarterly dividend declaration. The 2026 cadence ran declaration 2026-02-27 (payable 2026-04-03) and declaration 2026-06-03 (record 2026-06-17, payable 2026-07-02) at $0.135 per share. A rate increase against 1.9x net leverage would be management attaching cash to the post-divestiture story; a hold is the neutral outcome and the base rate.
• Any date through 2026-12-31 — Signing or closing of the Myers Tire Supply divestiture. No buyer, no price, no signed agreement has been announced as of 2026-08-23.
• ~2026-10-29 (est.) — Q3 2026 report. Outside the 30-day window, and named because it is the first measurable test of the H2 resin pricing recovery and the next opportunity to put a number on the qualitative FY26 outlook.

What Would Change Our Mind

The whole read rests on the post-print shelf holding. Price gapped through $31 on the Q2 beat and has held above it for four weeks; that shelf is what the July advance is built on, and losing it returns the stock to where it traded before the numbers that justified the re-rate. A weekly close below $31 hands back the entire post-Q2 advance and re-opens the gap toward the $27 June base. Separately, three fundamental conditions would break the frame independent of price: a Q3 gross margin printing below the 34.3% recorded in Q2, which would mean the resin pass-through failed twice; a further MTS impairment or withdrawal of the "close in 2026" language in the Q3 10-Q; and Infrastructure YoY growth decelerating from +52% to the low double digits, which removes the growth engine. On the other side, a signed MTS sale at or above post-impairment carrying value, or a second research desk initiating above the current market price, would widen a sponsor base that is currently one name.

Correlation Notes

• Input costs run with HD-polyethylene, which tracks ethylene feedstock and crude; the margin story is levered to resin more than to volume, as the 34.7% Q1 to 34.3% Q2 sequential step showed.
• Infrastructure demand (composite matting, ground protection) tracks utility, transmission and data-centre construction activity rather than the industrial production cycle, which is why Infrastructure grew 52% in Q2 while Industrial grew 2%.
• Vehicle ($20.5M, -19% YoY) and Consumer ($22.5M, -14% YoY) carry discretionary and auto-aftermarket beta and moved opposite the growth lines in the same quarter.
• With one deep sell-side sponsor, single-analyst actions dominate small-cap-industrial beta on any given day; the 2026-06-30 session moved 14% on a target revision alone.